---
$id: https://graph.org.ai/products/commodity/51302304
$type: Product
source: UNSPSC
code: "51302304"
title: "Brolaconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brolaconazole

**UNSPSC Code**: 51302304
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6CHG505391. European Medicines Agency schedules Brolaconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05902MIG. Brolaconazole generally arises in the molecular formula C17H15BRN2. The term BROLACONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) BROLACONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brolaconazole under HS 29332990 and SITC 51573. As of Q4 2014, BROLACONAZOLE remains the US FDA Preferred Term for this commodity. Brolaconazole bears US NLM identifiers UMLS ID C2347212 and NCI Concept Code C72957. SMILES: BRC1CCC(C(CN2CCNC2)C2CCCCC2)CC1.

